Japan Tissue Engineering Co., Ltd. (7774) Balance sheet
Market cap
¥23.5B
P/E ratio
235x
Develops and manufactures regenerative medicine products that restore tissue function by culturing patients' own cells for transplantation.
| 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Cash and cash equivalents | - | 5,966 | 3,854 | 4,090 | 6,204 | 5,930 | 5,751 | 5,276 | 4,933 | 4,135 | 4,266 | 3,885 | 3,250 |
| Inventories | - | - | - | - | - | 0 | 3 | 4 | - | - | - | 2 | 0 |
| Total current assets | - | 6,673 | 4,502 | 5,070 | 7,140 | 7,024 | 6,817 | 6,545 | 5,946 | 5,211 | 5,339 | 4,825 | 4,182 |
| Property, plant and equipment, net | - | 1,698 | 1,822 | 1,725 | 1,656 | 1,652 | 1,621 | 1,555 | 1,614 | 1,567 | 1,511 | 1,420 | 1,337 |
| Marketable securities, non-current | - | - | - | - | - | - | - | - | - | - | - | 150 | 100 |
| Total non-current assets | - | 2,156 | 3,780 | 3,470 | 1,883 | 1,728 | 1,635 | 1,575 | 1,652 | 1,672 | 1,649 | 1,688 | 1,501 |
| Total assets | - | 8,853 | 8,297 | 8,546 | 9,023 | 8,752 | 8,452 | 8,119 | 7,598 | 6,883 | 6,989 | 6,513 | 5,683 |
| Total current liabilities | - | 346 | 490 | 498 | 734 | 796 | 784 | 919 | 897 | 911 | 874 | 637 | 561 |
| Total non-current liabilities | - | 110 | 88 | 43 | 38 | 38 | 37 | 36 | 35 | 35 | 35 | 51 | 32 |
| Total liabilities | - | 456 | 578 | 541 | 772 | 834 | 821 | 955 | 932 | 946 | 908 | 688 | 593 |
| Retained earnings | - | -12,468 | -13,149 | 276 | 504 | 171 | -116 | -583 | -1,081 | -1,810 | -1,667 | -1,922 | -735 |
| Stockholders' equity | 2,163 | 8,397 | 7,718 | 8,005 | 8,251 | 7,918 | 7,631 | 7,164 | 6,666 | 5,937 | 6,080 | 5,825 | 5,090 |